Annual Cash & Cash Equivalents:
$47.92M-$17.14M(-26.35%)Summary
- As of today (October 3, 2025), ADPT annual cash & cash equivalents is $47.92 million, with the most recent change of -$17.14 million (-26.35%) on December 31, 2024.
- During the last 3 years, ADPT annual cash & cash equivalents has fallen by -$91.14 million (-65.54%).
- ADPT annual cash & cash equivalents is now -65.54% below its all-time high of $139.06 million, reached on December 31, 2021.
Performance
ADPT Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$197.87M+$4.45M(+2.30%)Summary
- As of today (October 3, 2025), ADPT quarterly cash & cash equivalents is $197.87 million, with the most recent change of +$4.45 million (+2.30%) on June 30, 2025.
- Over the past year, ADPT quarterly cash & cash equivalents has dropped by -$94.01 million (-32.21%).
- ADPT quarterly cash & cash equivalents is now -76.30% below its all-time high of $835.08 million, reached on September 30, 2020.
Performance
ADPT Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ADPT Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -26.4% | -32.2% |
| 3Y3 Years | -65.5% | -48.4% |
| 5Y5 Years | -50.4% | -65.3% |
ADPT Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -65.5% | at low | -61.0% | +2.3% |
| 5Y | 5-Year | -65.5% | at low | -76.3% | +2.3% |
| All-Time | All-Time | -65.5% | at low | -76.3% | +259.6% |
ADPT Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $197.87M(+2.3%) |
| Mar 2025 | - | $193.42M(-13.0%) |
| Dec 2024 | $47.92M(-26.3%) | $222.29M(-8.6%) |
| Sep 2024 | - | $243.33M(-16.6%) |
| Jun 2024 | - | $291.88M(-5.5%) |
| Mar 2024 | - | $308.87M(-10.8%) |
| Dec 2023 | $65.06M(-27.7%) | $346.40M(-6.7%) |
| Sep 2023 | - | $371.13M(-11.0%) |
| Jun 2023 | - | $417.23M(-5.3%) |
| Mar 2023 | - | $440.69M(-11.5%) |
| Dec 2022 | $90.03M(-35.3%) | $498.20M(-1.9%) |
| Sep 2022 | - | $508.08M(+32.4%) |
| Jun 2022 | - | $383.74M(+5.5%) |
| Mar 2022 | - | $363.56M(+3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $139.06M(+12.7%) | $353.06M(-14.9%) |
| Sep 2021 | - | $415.04M(-30.6%) |
| Jun 2021 | - | $598.41M(-16.2%) |
| Mar 2021 | - | $714.26M(+3.8%) |
| Dec 2020 | $123.44M(+27.8%) | $688.27M(-17.6%) |
| Sep 2020 | - | $835.08M(+46.4%) |
| Jun 2020 | - | $570.38M(+2.7%) |
| Mar 2020 | - | $555.17M(-3.8%) |
| Dec 2019 | $96.58M(+75.5%) | $576.87M(+0.6%) |
| Sep 2019 | - | $573.43M(+35.6%) |
| Jun 2019 | - | $423.00M(-4.0%) |
| Mar 2019 | - | $440.43M(+700.3%) |
| Dec 2018 | $55.03M(-35.5%) | $55.03M |
| Dec 2017 | $85.31M | - |
FAQ
- What is Adaptive Biotechnologies Corporation annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Adaptive Biotechnologies Corporation?
- What is Adaptive Biotechnologies Corporation annual cash & cash equivalents year-on-year change?
- What is Adaptive Biotechnologies Corporation quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Adaptive Biotechnologies Corporation?
- What is Adaptive Biotechnologies Corporation quarterly cash & cash equivalents year-on-year change?
What is Adaptive Biotechnologies Corporation annual cash & cash equivalents?
The current annual cash & cash equivalents of ADPT is $47.92M
What is the all-time high annual cash & cash equivalents for Adaptive Biotechnologies Corporation?
Adaptive Biotechnologies Corporation all-time high annual cash & cash equivalents is $139.06M
What is Adaptive Biotechnologies Corporation annual cash & cash equivalents year-on-year change?
Over the past year, ADPT annual cash & cash equivalents has changed by -$17.14M (-26.35%)
What is Adaptive Biotechnologies Corporation quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ADPT is $197.87M
What is the all-time high quarterly cash & cash equivalents for Adaptive Biotechnologies Corporation?
Adaptive Biotechnologies Corporation all-time high quarterly cash & cash equivalents is $835.08M
What is Adaptive Biotechnologies Corporation quarterly cash & cash equivalents year-on-year change?
Over the past year, ADPT quarterly cash & cash equivalents has changed by -$94.01M (-32.21%)